DB17774ExperimentalProtein Based Therapies
Cosfroviximab: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Envelope glycoprotein
- Also known as
- Immunoglobulin g1, anti-(ebolavirus/reston ebolavirus/sudan ebolavirus/tai forest ebolavirus glycoprotein) (human-mus musculus monoclonal c13c6-fr1 heavy chain), disulfide with human-mus musculus monoclonal c13c6-fr1 .kappa.-chain, dimer · Mb-003 component c13c6-fr1 · Zmapp component c13c6 · Zmapp component c13c6-fr1 · Zmapp component c13c6fr1
- Code names
- 13C6 · C13C6-FR1
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Cosfroviximab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account